Presentation TCT 2020 TCT 386: Diabetes Mellitus is Associated With Increased Risk of Early Stent Related Complications in Patients Undergoing Drug-Eluting Stent Implantation: Insight From the Victorian Cardiac Outcomes Registry (VCOR) Presenter: Jason Nogic October 14, 2020
Presentation TCT 2020 TCT 385: Placebo-Controlled Efficacy of Percutaneous Coronary Intervention for Focal and Diffuse Patterns of Stable Coronary Artery Disease: A Secondary Analysis From ORBITA Presenter: Christopher Rajkumar October 14, 2020
Presentation TCT 2020 TCT 383: Impact of Coronary Lesion Severity on Long Term Cardiac Outcomes in Renal Transplant Candidates Presenter: Maulin Shah October 14, 2020
Presentation TCT 2020 TCT 382: Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support Presenter: Nausharwan Butt October 14, 2020
Presentation TCT 2020 TCT 381: Predictors of Ischemic and Bleeding Outcomes in High Bleeding Risk Patients Implanted With the SYNERGY Stent – A Post-Hoc Analysis From the EVOLVE Short DAPT Study Presenter: Robert Yeh October 14, 2020
Presentation TCT 2020 TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population Presenter: Luca Testa October 14, 2020
Presentation TCT 2020 TCT 378: Sex Disparities Among Patients Undergoing Complex Percutaneous Coronary Intervention (PCI): Insights From a Single Center Large Volume PCI Registry Presenter: Johny Nicolas October 14, 2020
Presentation TCT 2020 TCT 377: Initial Optimal Medical Therapy With or Without Invasive Strategy for Stable Coronary Disease: A Meta-analysis and Systematic Review Presenter: Mahmoud Barbarawi October 14, 2020
Presentation TCT 2020 TCT 319: Risk Stratification of All-Cause Mortality Using Resistive Reserve Ratio in Patients With No Obstructive Coronary Artery Disease Presenter: Takumi Toya October 14, 2020
Presentation TCT 2020 TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion Presenter: Sandeep Basavarajaiah October 14, 2020
Presentation TCT 2020 TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy Presenter: Charan Yerasi October 14, 2020
Presentation TCT 2020 TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry) Presenter: Wojciech Wanha October 14, 2020
Presentation TCT 2020 TCT 278: Prevalence and Anatomical Factors Associated to Vascular Remodeling Following Bioresorbable Scaffold Implantation Presenter: Tatsuhiro Fujimura October 14, 2020
Presentation TCT 2020 TCT 276: A 'Real-World' Multi-center Registry Evaluating Safety and Clinical Performance of Biodegradable Polymer-coated Ultra-thin Everolimus-eluting Stents: 3-year Results from the PERFORM-EVER Registry Presenter: Sridhar Kasturi, MD October 14, 2020
Presentation TCT 2020 TCT 275: FANTOM II Long Lesion Study: Initial Safety & Performance Study of the Fantom Sirolimus-Eluting Bioresorbable Coronary Scaffold in Long Lesions – First Report: 1 Year Outcomes Presenter: Matthias Lutz October 14, 2020
Presentation TCT 2020 TCT 274: Adaptive Coronary Rotation in the Drug-Eluting Bioadaptor With Uncaging Segments Reduces Stress on the Coronary Artery Presenter: Mayank Kansal October 14, 2020
Presentation TCT 2020 TCT 273: Sirolimus Eluting, Tyrocore, Bioresorbable Vascular Scaffold Implantation in Patients with ST Segment Elevation Myocardial Infarction: 12 Month Outcomes – FANTOM STEMI Pilot Study Presenter: Lukasz Koltowski October 14, 2020
Presentation TCT 2020 TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions Presenter: Alexandre Abizaid October 14, 2020
Presentation TCT 2020 TCT 269: A First-in-Human Study of the Second-Generation, Thin-Strut, Everolimus-Eluting Bioresorbable Scaffold: Final IVUS and OCT Results From the FAST Clinical Trial Presenter: Takeshi Nishi October 14, 2020
Presentation TCT 2020 TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Adrian Wlodarczak October 14, 2020